Intuitive Surgical, Inc. $ISRG Holdings Lifted by Verdence Capital Advisors LLC

Verdence Capital Advisors LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 209.3% in the third quarter, Holdings Channel reports. The institutional investor owned 6,886 shares of the medical equipment provider’s stock after acquiring an additional 4,660 shares during the period. Verdence Capital Advisors LLC’s holdings in Intuitive Surgical were worth $2,800,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the business. Flagship Harbor Advisors LLC grew its holdings in Intuitive Surgical by 36.8% during the 3rd quarter. Flagship Harbor Advisors LLC now owns 2,703 shares of the medical equipment provider’s stock valued at $1,099,000 after purchasing an additional 727 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its position in Intuitive Surgical by 235.8% in the 3rd quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 138,050 shares of the medical equipment provider’s stock worth $56,135,000 after purchasing an additional 96,938 shares during the period. Aries Wealth Management lifted its stake in Intuitive Surgical by 5.6% in the third quarter. Aries Wealth Management now owns 1,224 shares of the medical equipment provider’s stock worth $498,000 after purchasing an additional 65 shares during the last quarter. Tower View Wealth Management LLC boosted its position in shares of Intuitive Surgical by 3.6% during the third quarter. Tower View Wealth Management LLC now owns 5,919 shares of the medical equipment provider’s stock valued at $2,407,000 after buying an additional 206 shares during the period. Finally, Hilton Head Capital Partners LLC boosted its position in shares of Intuitive Surgical by 35.2% during the third quarter. Hilton Head Capital Partners LLC now owns 173 shares of the medical equipment provider’s stock valued at $70,000 after buying an additional 45 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG stock opened at $445.88 on Wednesday. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The business has a 50-day moving average price of $398.31 and a 200 day moving average price of $436.15.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. The firm’s revenue was up 21.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.40 earnings per share. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. BMO Capital Markets reissued an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. TD Cowen reiterated a “buy” rating and set a $485.00 target price on shares of Intuitive Surgical in a research report on Monday, October 19th. Royal Bank Of Canada lowered their target price on shares of Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating for the company in a research note on Wednesday, October 21st. Stifel Nicolaus cut their price target on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a report on Friday, July 17th. Finally, JPMorgan Chase & Co. raised their price target on shares of Intuitive Surgical from $450.00 to $475.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 21st. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $493.54.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Mark Brosius sold 77 shares of the company’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $375.57, for a total transaction of $28,918.89. Following the completion of the sale, the executive vice president owned 881 shares in the company, valued at $330,877.17. This represents a 8.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig H. Barratt sold 1,150 shares of the stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $510,370.00. Following the sale, the director directly owned 1,150 shares in the company, valued at $510,370. This trade represents a 50.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 38,684 shares of company stock worth $16,770,301. Insiders own 0.60% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street remains broadly constructive: the average brokerage recommendation is equivalent to a Buy, while the reported consensus price target of $493.54 is above recent trading levels. However, the article cautions that sell-side ratings can be overly optimistic. Wall Street bullish views on ISRG
• Positive Sentiment: Analysts have been raising earnings estimates, and Zacks highlighted ISRG’s growth profile. The company’s latest quarterly results provide fundamental support, with revenue up 21.7% year over year to $3.05 billion and earnings of $3.00 per share versus a $2.65 consensus estimate. Higher earnings estimates
• Neutral Sentiment: ISRG is attracting substantial investor attention, which may increase trading activity but does not necessarily signal a change in business fundamentals. Reported short interest of zero shares and a zero-day days-to-cover ratio also appear inconsistent with the description of a significant increase, limiting the data’s usefulness. ISRG trending-stock analysis
• Negative Sentiment: Several insiders sold shares under pre-arranged Rule 10b5-1 plans. Director Gary Guthart sold approximately $9.1 million, while a vice president, senior vice president and another director also reduced their holdings. Although planned sales are not necessarily bearish, the cluster may weigh on sentiment. ISRG insider selling
• Negative Sentiment: Valuation remains a key risk. ISRG trades at roughly 54 times earnings and a PEG ratio above 3, leaving limited room for execution disappointments. The stock’s decline below its 200-day moving average may also indicate near-term technical weakness.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.